IMNM Immunome Inc

USD 10.27 -0.95 ( -8.47%)
Icon

Immunome Inc (IMNM) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 10.27

-0.95 (-8.47%)

USD 0.92B

1.42M

USD 28.60(+178.48%)

N/A

Icon

IMNM

Immunome Inc (USD)
COMMON STOCK | NSD
USD 10.27
-0.95 ( -8.47%)
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.92B

N/A

USD 10.27

Immunome Inc (IMNM) Stock Forecast

Show ratings and price targets of :
USD 28.60
(+178.48%)

Based on the Immunome Inc stock forecast from 2 analysts, the average analyst target price for Immunome Inc is USD 28.60 over the next 12 months. Immunome Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Immunome Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Immunome Inc’s stock price was USD 10.27. Immunome Inc’s stock price has changed by -7.31% over the past week, -3.11% over the past month and -55.56% over the last year.

No recent analyst target price found for Immunome Inc
No recent average analyst rating found for Immunome Inc

Company Overview Immunome Inc

Immunome, Inc., a biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises AL102, an investigational gamma secretase inhibitor currently in evaluation in a Phase 3 trial for the treatment of desmoid tumors; and preclinical assets consist o...Read More

https://immunome.com

18702 N. Creek Parkway, Bothell, WA, United States, 98011

55

December

USD

USA

Adjusted Closing Price for Immunome Inc (IMNM)

Loading...

Unadjusted Closing Price for Immunome Inc (IMNM)

Loading...

Share Trading Volume for Immunome Inc Shares

Loading...

Compare Performance of Immunome Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for IMNM

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Immunome Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -14.75 (-3.14%) USD118.90B 32.57 220.35

Frequently Asked Questions About Immunome Inc (IMNM) Stock

Based on ratings from 2 analysts Immunome Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 5 buy, sell and hold ratings.

Unfortunately we do not have enough data on IMNM's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for IMNM is USD 28.60 over the next 12 months. The maximum analyst target price is USD 33 while the minimum anlayst target price is USD 21.

Unfortunately we do not have enough data on IMNM's stock to indicate if its overvalued.

The last closing price of IMNM's stock was USD 10.27.

The most recent market capitalization for IMNM is USD 0.92B.

Based on targets from 2 analysts, the average taret price for IMNM is projected at USD 28.60 over the next 12 months. This means that IMNM's stock price may go up by +178.48% over the next 12 months.

We can't find any ETFs which contains Immunome Inc's stock.

As per our most recent records Immunome Inc has 55 Employees.

Immunome Inc's registered address is 18702 N. Creek Parkway, Bothell, WA, United States, 98011. You can get more information about it from Immunome Inc's website at https://immunome.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Immunome Inc (IMNM) Stock

Based on ratings from 2 analysts Immunome Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 5 buy, sell and hold ratings.

Unfortunately we do not have enough data on IMNM's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for IMNM is USD 28.60 over the next 12 months. The maximum analyst target price is USD 33 while the minimum anlayst target price is USD 21.

Unfortunately we do not have enough data on IMNM's stock to indicate if its overvalued.

The last closing price of IMNM's stock was USD 10.27.

The most recent market capitalization for IMNM is USD 0.92B.

Based on targets from 2 analysts, the average taret price for IMNM is projected at USD 28.60 over the next 12 months. This means that IMNM's stock price may go up by +178.48% over the next 12 months.

We can't find any ETFs which contains Immunome Inc's stock.

As per our most recent records Immunome Inc has 55 Employees.

Immunome Inc's registered address is 18702 N. Creek Parkway, Bothell, WA, United States, 98011. You can get more information about it from Immunome Inc's website at https://immunome.com.
Loading...